Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

ImClone Systems earns manufacturing milestone from Merck KGaA

Aug. 4, 1997

GnRH conjugate vaccines prepared at Merck & Co.

July 30, 1997

FDA advisory committee recommends approval of rituximab

July 28, 1997

Bristol-Myers Squibb licenses cancer vaccines from Progenics

July 18, 1997

Low-dose interferon alfa nears phase III for the treatment of Sjogren's syndrome

July 17, 1997

Maxamine enters phase III for malignant melanoma

July 15, 1997

Jenner Technologies reports results from phase I/II trial of prostate cancer vaccine

July 9, 1997

MDX-210 shows promise in advanced kidney and prostate cancer

July 1, 1997

Ajinomoto prepares peptides for treating or preventing human gastric cancer

June 30, 1997

Novopharm Biotech issued U.S. patent for two human monoclonal antibodies

June 27, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 12, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...